(Q39703413)

14 September 2017

Evidence of constitutional MLH1 epimutation associated to transgenerational inheritance of cancer susceptibility (English)

1 reference

14 September 2017

10

Marie-Pierre Buisine

0 references

author name string

Michel Crépin

1

1 reference

14 September 2017

Marie-Claire Dieu

2

1 reference

14 September 2017

Sophie Lejeune

3

1 reference

14 September 2017

Fabienne Escande

4

1 reference

14 September 2017

Denis Boidin

5

1 reference

14 September 2017

Nicole Porchet

6

1 reference

14 September 2017

Gilles Morin

7

1 reference

14 September 2017

Sylvie Manouvrier

8

1 reference

14 September 2017

Michèle Mathieu

9

1 reference

14 September 2017

31 October 2011

1 reference

14 September 2017

1 reference

14 September 2017

33

1 reference

14 September 2017

1

1 reference

14 September 2017

180-188

1 reference

Identification and characterization of a novel MLH1 genomic rearrangement as the cause of HNPCC in a Tunisian family: evidence for a homologous Alu-mediated recombination

14 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

The role of parental and grandparental epigenetic alterations in familial cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

Classification of colorectal cancer based on correlation of clinical, morphological and molecular features

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

Molecular screening for Lynch syndrome: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

Recurrence and variability of germline EPCAM deletions in Lynch syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

Extensive but hemiallelic methylation of the hMLH1 promoter region in early-onset sporadic colon cancers with microsatellite instability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

Germline epimutation of MLH1 in individuals with multiple cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

MLH1 Germline Epimutations as a Factor in Hereditary Nonpolyposis Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

Inheritance of a Cancer-AssociatedMLH1Germ-Line Epimutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting Highlights and Bethesda Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

Hereditary colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

inferred from DOI database lookup

7 January 2021

based on heuristic

Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

inferred from DOI database lookup

7 January 2021

based on heuristic

MLH1 germline epimutations in selected patients with early-onset non-polyposis colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21617

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HUMU.21617

1 reference

14 September 2017

1 reference